- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin glargine/Lixisenatide (HOE901/AVE0010)
Total 582 results
-
SanofiActive, not recruiting
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Chile, Colombia, Germany, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Turkey
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
SanofiCompletedDiabetes Mellitus, Type 2Australia, United Kingdom
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Brazil, Poland, Romania, Russian Federation, Ukraine
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
-
SanofiTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Czechia, Hungary, Poland, Serbia
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusChina, India, Korea, Republic of, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusSouth Africa, United States, Mexico, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
SanofiProfil GmbH, Neuss, GermanyCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
SanofiCompletedAcute Coronary SyndromeBelgium, China, Japan, Denmark, United States, Belarus, Mexico, Philippines, Israel, Austria, Serbia, Estonia, Lithuania, Chile, Colombia, Germany, Latvia, Peru, Ukraine, Egypt, Italy, France, Brazil, India, Guatemala, South Africa, Taiwan, C... and more
-
SanofiTerminatedDiabetes Mellitus, Type 2Australia
-
SanofiTerminatedType II Diabetes Mellitus
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, Thailand, Slovakia, Poland, Netherlands, Kuwait, Mexico, Korea, Republic of, Czech Republic, Egypt, France, Italy, Romania, Russian Federation, Sweden, Switzerland, United Arab Emirates
-
SanofiCompletedDiabetes Mellitus, Type 2Israel, Czechia, Greece, Italy, United States, Bulgaria, Croatia, Denmark, France, Hungary, Romania, Serbia, Slovakia, Sweden, Switzerland, United Kingdom
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusTurkey, Netherlands, Brazil, United States, Germany, Hungary, United Kingdom
-
Heidelberg UniversityUnknown
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
SanofiTerminated
-
Laniado HospitalTerminatedDiabetes Mellitus Type 2Israel
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Romania, Ukraine, Germany, Italy, Estonia, Malaysia, Philippines, Mexico, Lithuania, Colombia, Slovakia, Chile
-
SanofiCompletedType 2 Diabetes MellitusChina, Hong Kong, Malaysia, Thailand
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Bulgaria, Canada, Denmark, Germany, Norway, Peru, Poland, South Africa, Spain, Sweden, United Kingdom
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
SanofiCompletedType 2 Diabetes MellitusChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Germany, Turkey, Greece
-
SanofiCompletedType 2 Diabetes MellitusSpain, United States, Canada, Czech Republic, France, Germany, Poland, Romania, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
IRCCS San RaffaeleTerminatedType 2 Diabetes Mellitus | Peripheral Vascular DiseaseItaly